Intense and allegedly inaccurate media scrutiny focusing on pelvic mesh products and the string of recent multimillion-dollar verdicts has tainted the Philadelphia jury pool, Johnson & Johnson subsidiary Ethicon has argued in a bid to have upcoming pelvic mesh trials moved out of the Philadelphia area.

Last week, Ethicon, the primary defendant in nearly 90 pelvic mesh cases pending in Philadelphia, filed a motion seeking to either have trials moved to a venue outside the five-county suburban Philadelphia area, or have a “pretrial cooling off-period” before beginning the next trial.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]